Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01237561 · ClinicalTrials.gov registry record · NA

Translating The GOLD COPD Guidelines Into Primary Care Practice

A NA study, sponsored by Memorial Hospital of Rhode Island.

Completed
Registry status
NA
Development phase
3,593
Enrollment target

NCT01237561 is a NA study that has completed, run by Memorial Hospital of Rhode Island. The registered enrollment target is 3,593 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01237561, a NA study, has completed, sponsored by Memorial Hospital of Rhode Island.

COMPLETED
Registry status
NA
Development phase
3,593 participants
Enrollment target

Study Summary

This project will evaluate the translation of the Gold (the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease) COPD guidelines into primary care practice. During phase I, a needs assessment will evaluate barriers and facilitators to implementation of COPD guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from the focus groups, three tools will be developed, refined and pilot tested. The effectiveness of the materials developed in phase I will be tested in phase II (a randomized clinical trial conducted with one year of intervention within non-academic primary care practices) regarding physician performance of COPD guideline implementation and improvement in the clinically relevant outcomes (appropriate screening, diagnosis and management of COPD) compared to usual care.

Interventions

  • OTHER provider support tools plus spirometer

Trial Details

FieldValue
Enrollment Target 3,593 participants
Start Date 2010-10
Est. Completion 2013-10-25
Phase NA

What the Registry Record Tells You About NCT01237561

The ClinicalTrials.gov registry entry for NCT01237561 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,593 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Hospital of Rhode Island, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which provider support tools plus spirometer is the first listed.

NCT01237561 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01237561 about?

NCT01237561 is a clinical study titled "Translating The GOLD COPD Guidelines Into Primary Care Practice". This project will evaluate the translation of the Gold (the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease) COPD guidelines into primary care practice. During phase I, a needs assessment will evaluate barriers and facilitators to implementation...

What is the current status of trial NCT01237561?

This trial is currently completed. It is a NA study. The enrollment target is 3,593 participants. The study started on 2010-10. Estimated completion is 2013-10-25.

What interventions are being tested in trial NCT01237561?

The interventions under investigation include: provider support tools plus spirometer (OTHER).

Who is sponsoring clinical trial NCT01237561?

This trial is sponsored by Memorial Hospital of Rhode Island, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.